174 related articles for article (PubMed ID: 20099350)
1. Comparison of two different injection rates of gadoxetic acid for arterial phase MRI of the liver.
Chung SH; Kim MJ; Choi JY; Hong HS
J Magn Reson Imaging; 2010 Feb; 31(2):365-72. PubMed ID: 20099350
[TBL] [Abstract][Full Text] [Related]
2. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.
Sun HY; Lee JM; Shin CI; Lee DH; Moon SK; Kim KW; Han JK; Choi BI
Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319
[TBL] [Abstract][Full Text] [Related]
3. Timing of the hepatic arterial phase at Gd-EOB-DTPA-enhanced hepatic dynamic MRI: comparison of the test-injection and the fixed-time delay method.
Nakamura S; Nakaura T; Kidoh M; Utsunomiya D; Doi Y; Harada K; Uemura S; Yamashita Y
J Magn Reson Imaging; 2013 Sep; 38(3):548-54. PubMed ID: 23744782
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of liver parenchyma after injection of hepatocyte-specific MRI contrast media: a comparison of gadoxetic acid and gadobenate dimeglumine.
Filippone A; Blakeborough A; Breuer J; Grazioli L; Gschwend S; Hammerstingl R; Heinz-Peer G; Kittner T; Laghi A; Leen E; Lencioni R; Lucidarme O; Remplik P; Robinson PJ; Ruehm SG; Schaefer F; Stoupis C; Tombach B; Valette PJ; Zech CJ; Huppertz A
J Magn Reson Imaging; 2010 Feb; 31(2):356-64. PubMed ID: 20099349
[TBL] [Abstract][Full Text] [Related]
5. Normal dynamic MRI enhancement patterns of the upper abdominal organs: gadoxetic acid compared with gadobutrol.
Kühn JP; Hegenscheid K; Siegmund W; Froehlich CP; Hosten N; Puls R
AJR Am J Roentgenol; 2009 Nov; 193(5):1318-23. PubMed ID: 19843748
[TBL] [Abstract][Full Text] [Related]
6. Dynamic and delayed contrast enhancement in upper abdominal MRI studies: comparison of gadoxetic acid and gadobutrol.
Zizka J; Klzo L; Ferda J; Mrklovský M; Bukac J
Eur J Radiol; 2007 May; 62(2):186-91. PubMed ID: 17367974
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of controlled aliasing in parallel imaging results in higher acceleration in gadoxetic acid-enhanced liver magnetic resonance imaging to clarify the hepatic arterial phase.
Park YS; Lee CH; Kim IS; Kiefer B; Woo ST; Kim KA; Park CM
Invest Radiol; 2014 Mar; 49(3):183-8. PubMed ID: 24276676
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient.
Kim HJ; Kim BS; Kim MJ; Kim SH; de Campos RO; Hernandes M; Semelka RC
J Magn Reson Imaging; 2013 Apr; 37(4):903-8. PubMed ID: 23065959
[TBL] [Abstract][Full Text] [Related]
9. Comparison of three different injection methods for arterial phase of Gd-EOB-DTPA enhanced MR imaging of the liver.
Tamada T; Ito K; Yoshida K; Kanki A; Higaki A; Tanimoto D; Higashi H
Eur J Radiol; 2011 Dec; 80(3):e284-8. PubMed ID: 21296514
[TBL] [Abstract][Full Text] [Related]
10. Fat-suppressed dynamic and delayed gadolinium-enhanced volumetric interpolated breath-hold magnetic resonance imaging of cholangiocarcinoma.
Leyendecker JR; Gakhal M; Elsayes KM; McDermott R; Narra VR; Brown JJ
J Comput Assist Tomogr; 2008; 32(2):178-84. PubMed ID: 18379298
[TBL] [Abstract][Full Text] [Related]
11. Detection and characterization of focal hepatic tumors: a comparison of T2-weighted MR images before and after the administration of gadoxectic acid.
Kim YK; Kwak HS; Kim CS; Han YM
J Magn Reson Imaging; 2009 Aug; 30(2):437-43. PubMed ID: 19629973
[TBL] [Abstract][Full Text] [Related]
12. Hepatic arterial phase on gadoxetic acid-enhanced liver MR imaging: a randomized comparison of 0.5 mL/s and 1 mL/s injection rates.
Kim SM; Heo SH; Kim JW; Lim HS; Shin SS; Jeong YY; Kang HK
Korean J Radiol; 2014; 15(5):605-12. PubMed ID: 25246821
[TBL] [Abstract][Full Text] [Related]
13. Dilution method of gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI).
Motosugi U; Ichikawa T; Sou H; Sano K; Ichikawa S; Tominaga L; Araki T
J Magn Reson Imaging; 2009 Oct; 30(4):849-54. PubMed ID: 19787734
[TBL] [Abstract][Full Text] [Related]
14. Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA.
Tamada T; Ito K; Sone T; Yamamoto A; Yoshida K; Kakuba K; Tanimoto D; Higashi H; Yamashita T
J Magn Reson Imaging; 2009 Mar; 29(3):636-40. PubMed ID: 19243060
[TBL] [Abstract][Full Text] [Related]
15. Whole-body MRI with assessment of hepatic and extraabdominal enhancement after administration of gadoxetic acid for staging of rectal carcinoma.
Huppertz A; Franiel T; Wagner M; Püttcher O; Wagner J; Rief M; Schwenke C; Hamm B; Strassburg J
Acta Radiol; 2010 Oct; 51(8):842-50. PubMed ID: 20698804
[TBL] [Abstract][Full Text] [Related]
16. Dual double arterial phase dynamic MR imaging with sensitivity encoding (SENSE): which is better for diagnosing hypervascular hepatocellular carcinomas, in-phase or opposed-phase imaging?
Yoshioka H; Sato J; Takahashi N; Lou D; Yamaguchi M; Saida Y; Itai Y
Magn Reson Imaging; 2004 Apr; 22(3):361-7. PubMed ID: 15062931
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of optimal scan delay for gadoxetate disodium-enhanced hepatic arterial phase MRI using MR fluoroscopic triggering and slow injection technique.
Goshima S; Kanematsu M; Kondo H; Watanabe H; Kawada H; Moriyama N; Bae KT
AJR Am J Roentgenol; 2013 Sep; 201(3):578-82. PubMed ID: 23971449
[TBL] [Abstract][Full Text] [Related]
18. Combined gadoxetic acid and gadofosveset enhanced liver MRI: A feasibility and parameter optimization study.
Bannas P; Motosugi U; Hernando D; Rahimi MS; Holmes JH; Reeder SB
Magn Reson Med; 2016 Jan; 75(1):318-28. PubMed ID: 25648403
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a novel time-efficient protocol for gadobenate dimeglumine (Gd-BOPTA)-enhanced liver magnetic resonance imaging.
Schneider G; Altmeyer K; Kirchin MA; Seidel R; Grazioli L; Morana G; Saini S
Invest Radiol; 2007 Feb; 42(2):105-15. PubMed ID: 17220728
[TBL] [Abstract][Full Text] [Related]
20. Hepatic Arterial Phase in Gadoxetic Acid-Enhanced Liver Magnetic Resonance Imaging: Analysis of Respiratory Patterns and Their Effect on Image Quality.
Park YS; Lee CH; Yoo JL; Kim IS; Kiefer B; Woo ST; Kim KA; Park CM
Invest Radiol; 2016 Feb; 51(2):127-33. PubMed ID: 26418367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]